Press Releases

EndoBarrier Study Shows Improvement in Cardiovascular Risk

BOSTON and SYDNEY — 15 January 2020 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce positive EndoBarrier data from the University of Freiburg in Germany showing improvements of...

read more

Confirmation of Funding of 2019 Note and Issuance of Warrants

BOSTON and SYDNEY — 14 January 2020 — GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that further to its announcements of 22 August 2019, 6 December 2019, 9 December 2019 and 17 December...

read more

Videos